Complement 1, a health tech company transforming cancer care through personalized lifestyle medicine, announced a $16 million oversubscribed seed funding round led by Owl Ventures and Blume Ventures. It also includes participation from healthcare-focused angel investors, reflecting widespread investor confidence in the company’s impact and market potential.Read More
Complement 1: $16 Million Seed Raised For Scaling Validated Cancer Lifestyle Modification Platform
